Home - Products - Apoptosis - TNF - CDC801

CDC801

CAS No. 192819-27-5

CDC801( CDC-801 )

Catalog No. M26097 CAS No. 192819-27-5

CDC801 is a potent and orally active inhibitor of PDE4 and TNF-α (IC50: 1.1 μM and 2.5 μM).

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	358	Get Quote
5MG	560	Get Quote
10MG	799	Get Quote
25MG	1197	Get Quote
50MG	1611	Get Quote
100MG	2187	Get Quote
200MG	Get Quote	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

CDC801
Note

Research use only, not for human use.
Brief Description

CDC801 is a potent and orally active inhibitor of PDE4 and TNF-α (IC50: 1.1 μM and 2.5 μM).
Description

CDC801 is a potent and orally active inhibitor of PDE4 and TNF-α (IC50: 1.1 μM and 2.5 μM).
In Vitro

The more detailed information refer to the Compound 6b in the reference 1 (PMID:19256507).
In Vivo

——
Synonyms

CDC-801
Pathway

Apoptosis
Target

TNF
Recptor

Potassium Channel
Research Area

——
Indication

——

Chemical Information

CAS Number

192819-27-5
Formula Weight

408.454
Molecular Formula

C23H24N2O5
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 16.67 mg/mL (40.81 mM)
SMILES

COc1ccc(cc1OC1CCCC1)C(CC(N)=O)N1C(=O)c2ccccc2C1=O
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Hamilton KL,et al. DCEBIO stimulates Cl- secretion in the mouse jejunum. Am J Physiol Cell Physiol. 2006 Jan;290(1):C152-64.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Belimumab

Belimumab(LymphoStat B) is a human IgG1λ monoclonal antibody that inhibits B-cell activating factor (BAFF).Belimumab is used in the study of fatigue and in the treatment of lupus nephritis and systemic lupus erythematosus.
UCB-9260

UCB-9260 inhibits TNF signaling by stabilizing an asymmetric form of the trimer.
Atibuclimab

Atibuclimab is a chimeric monoclonal antibody targeting CD14, consisting of a mouse variable region and a human IgG4 Fc region.

Sign In Join Free